Business Context and Reporting Period
Company: Capricor Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 10, 2015
Event: Regulation FD Disclosure regarding the posting of a Corporate Presentation to update investors on the Company's current business and products.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to announce the availability of a corporate presentation rather than to report financial results.
Material Changes
No material financial changes or operational updates are detailed within the text of this Form 8-K. The document references an attached Exhibit 99.1 (Corporate Presentation) for detailed business updates, but the content of that presentation is not included in the provided text.
Guidance, Outlook, and Risks
Management Commentary: The Company posted a Corporate Presentation to provide an update on its business and products.
Legal Disclaimer: The information contained in this Form 8-K and the attached presentation is furnished and shall not be deemed "filed" under Section 18 of the Securities Exchange Act of 1934. It is not subject to the liabilities of that section and shall not be incorporated by reference into other filings unless expressly stated.
Risks/Contingencies: No specific risks or contingencies are listed in the text of this filing.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Corporate Presentation) for specific details on business updates and product status.
- Verify the presentation content on the Company's website at www.capricor.com under the "Investors" section.
- Note that the presentation is not legally "filed" with the SEC and carries different liability standards than a formal 10-K or 10-Q.